Navigation path

COMMISSION IMPLEMENTING DECISION of 9.11.2021 granting an authorisation under REACH to Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim RCV GmbH & Co KG for a use of 4-tert-OPnEO

Download links: